Genesis Healthcare offers complete end-to-end genetic services to researchers, corporations and consumers alike
POPULATION GENOMIC PLATFORM
Unlocking the power of genetic data for research and development
GenesisGaia is a genomic platform allowing researchers to access the largest Japanese population genomic database.
With rich genetic and phenotypic data sets as well as advanced visualizations and prediction models, GenesisGaia supports researchers to accelerate their R&D initiatives for new product developments as well as medical and drug discoveries.
R&D & DIAGNOSTICS
Clinical genomic sequencing, diagnostic and screening services to medical and healthcare institutions and a variety of industries
Since our inception, our aim has been to support healthcare providers, medical institutions and universities in their research programs.
GenesisPro offers a range of services covering screening for cancers and lifestyle-related diseases, pharmacogenomics and food-safety testing.
OUR DIRECT-TO-CONSUMER GENETIC
GeneLife is the leader of direct-to-consumer genetic testing in Japan, with more than 70% market share (source: Fuji Chimera Research Institute).
Genesis 2.0 Plus is our most comprehensive genetic test kit that scans for over 360 traits to uncover potential health risks, diseases and conditions.
In addition to that, GeneLife also offers a range of kits covering ancestry, personality, nutrition, fitness and beauty.
JAPAN'S FIRST WHOLE GENOME SEQUENCING GENETIC TEST KIT
Based on state-of-the-art technology, more than 6,500 items are analyzed at once. After 19 years of genetic research, Genesis Healthcare is the first in Japan to offer whole genome analysis at a price and service affordable to the general public.
The test includes a consultation with a medical professional to review the results.
INFECTIOUS DISEASE TESTING
COVID-19 PCR test
Collection of saliva sample from the comfort of home, including consultation with a doctor and results available via smartphone.
A convenient and safe COVID-19 PCR test kit, analyzed under strict international and Japanese standards at Genesis Healthcare’s laboratory in Tokyo.